Laboratory to Perform Assays of Coagulopathy Biomarkers for the National Cancer Institute’s COVID-19 in Cancer Patients Study (NCCAPS)

$4.06M USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Unknown
Country	United States
Start Date	Mar 01, 2021
End Date	Feb 28, 2022
Duration	364 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10461598`

Grant Description

Lab will conduct coagulopathy assays for NCI to analyze as part of a correlative science objective in NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study, ClinicalTrials.gov Identifier: NCT04387656 https://clinicaltrials.gov/ct2/show/NCT04387656